Related Experiment Video

Updated: Apr 17, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.7K

Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways

Amrita Chatterjee1, Suman Mukhopadhyay1, Kaity Tung1

  • 1Department of Biological Sciences, Hunter College of the City University of New York, New York, NY, USA.

Cancer Letters
|February 10, 2015
PubMed

Insights

Mammalian target of rapamycin complex 1 (mTORC1) regulates cell cycle progression. Suppressing mTORC1 with rapamycin induces G1 cell cycle arrest by up-regulating TGF-β signaling and down-regulating Rb phosphorylation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell cycle progression.
  • mTORC1 influences G1 phase progression through substrates like S6K and 4E-BP1.
  • Previous work showed simultaneous S6K and eIF4E knockdown causes TGF-β-dependent G1 arrest in breast cancer cells.

Purpose of the Study:

  • To investigate the role of mTORC1 substrates in TGF-β-dependent G1 cell cycle arrest.
  • To determine the critical mTORC1 target responsible for promoting cell cycle progression.
  • To elucidate the mechanisms underlying rapamycin-induced G1 arrest.

Main Methods:

  • Utilized MDA-MB-231 human breast cancer cells.
  • Administered varying concentrations of rapamycin to assess differential inhibition of mTORC1 substrates.
  • Analyzed TGF-β signaling, Rb phosphorylation, and cell cycle progression.

Main Results:

  • Rapamycin inhibited S6K phosphorylation at nanomolar concentrations but required micromolar concentrations for 4E-BP1 inhibition.
  • Micromolar rapamycin doses were necessary for complete G1 cell cycle arrest, implicating 4E-BP1 as a critical target.
  • Rapamycin-induced G1 arrest resulted from increased TGF-β signaling and decreased Rb phosphorylation.

Conclusions:

  • 4E-BP1 is a critical target of mTORC1 for promoting cell cycle progression.
  • mTORC1 suppression, particularly targeting 4E-BP1, can induce G1 cell cycle arrest.
  • Findings provide insights into the cytostatic effects of mTORC1 inhibition with potential therapeutic applications in cancer.
Keywords:
RapamycinRbTGF-βeIF4EmTOR

More Related Videos

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

11.3K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

887

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K